English | Chinese
News

Position:Home > News > content

News
Artemisinin Resistance
Class:News    Time:2015/7/4 17:30:55   Hits:889  Back

      Clinical evidence for artemisinin resistance in southeast Asia was first reported in 2008, and was subsequently confirmed by a detailed study from western Cambodia. Resistance in neighbouring Thailand was reported in 2012, and in Northern Cambodia, Vietnam and Eastern Myanmar in 2014. Emerging resistance was reported in Southern Laos, central Myanmar and North-Eastern Cambodia in 2014. The parasite's kelch gene on chromosome 13 appears to be a reliable molecular marker for clinical resistance in southeast Asia.

 

      In April 2011, the WHO stated that resistance to the most effective antimalarial drug, artemisinin, could unravel national (India) malaria control programs, which have achieved significant progress in the last decade. WHO advocates the rational use of antimalarial drugs and acknowledges the crucial role of community health workers in reducing malaria in the region.

Our Address
  • Address: NO. 318, TAOYUAN RD, YONGZHOU, HUNAN PROVINCE, CHINA
  • Tel: 86-0746-8227298/ 13574632391
  • E_mail: yzsunco@hotmail.com
Copyright © 2005-2020 Hunan Xingchen Biotechnology Co.,Ltd